MF6 logo

MagForce Stock Price

Symbol: XTRA:MF6Market Cap: €3.6mCategory: Healthcare

MF6 Share Price Performance

MF6 Community Fair Values

    Recent MF6 News & Updates

    No updates

    MagForce AG Key Details

    €1.1m

    Revenue

    €918.7k

    Cost of Revenue

    €158.4k

    Gross Profit

    €10.7m

    Other Expenses

    -€10.6m

    Earnings

    Last Reported Earnings
    Dec 31, 2021
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.35
    Gross Margin
    14.70%
    Net Profit Margin
    -981.70%
    Debt/Equity Ratio
    95.5%

    MagForce AG Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About MF6

    Founded
    1997
    Employees
    33
    CEO
    Benjamin Lipps
    WebsiteView website
    www.magforce.com

    MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of brain tumors; NanoPlan, a software that supports the attending physician in preparing the ideal treatment plan for the NanoTherm therapy; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.

    German Market Performance

    • 7 Days: 2.5%
    • 3 Months: 4.5%
    • 1 Year: 18.6%
    • Year to Date: 7.6%
    The market is up 2.5% over the last week, with the Communication Services sector leading the way, up 14%. On the other hand, with a decline of 3.2%, the Consumer Discretionary sector is lagging behind. The market is up 19% over the last 12 months. Looking forward, earnings are forecast to grow by 16% annually. Market details ›
    Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
    Continue reading